Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 19 Carcinoma, Non-Small-Cell Lung 9 Rhabdomyosarcoma 6 Triple Negative Breast Neoplasms 5 Hodgkin Disease 4 Recurrence 3 Neoplasms 3 Uterine Cervical Neoplasms 2 Sarcoma 2 Rhabdomyosarcoma, Embryonal 2 Rhabdomyosarcoma, Alveolar 2 Neoplasm Metastasis 2 Lung Neoplasms 2 Adenocarcinoma 2 Solitary Fibrous Tumor, Pleural 1 NSCLC 1 Metastatic HER2-positive Breast Cancer 1 Mesothelioma, Malignant 1 Lung Diseases, Interstitial 1 Locally Advanced Non-Small Cell Lung Cancer 1 HR+HER2- Breast Cancer 1 Fludzoparib" and Anti-angiogenic 1 Desmoplastic Small Round Cell Tumor 1 Colonic Neoplasms 1 Carcinoma, Squamous Cell 1 Carcinoma, Large Cell 1 Advanced Breast Cancer 1

Interventions

Letrozole 5 Fulvestrant 5 trastuzumab deruxtecan 3 Injections 3 toripalimab 2 sacituzumab govitecan 2 palbociclib 2 elacestrant 2 abemaciclib 2 Anastrozole 2 AZD9833 2 ribociclib 1 pyrotinib 1 exemestane 1 eribulin 1 disitamab vedotin 1 dalpiciclib 1 Vinorelbine 1 Selective Estrogen Receptor Modulators 1 Ritonavir 1 RAD1901 1 Paclitaxel 1 Lead 1 Itraconazole 1 Goserelin 1 Gonadotropin-Releasing Hormone 1 Everolimus 1 Docetaxel 1 Bevacizumab 1 Aromatase Inhibitors 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Advanced Breast Cancer × Vinorelbine × 1 year × Clear all

NCT06500494 2025-07-24

VINOREAL

Pierre Fabre Medicament

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡